Identifying biomarkers from pacemaker and defibrillator sensors

  • Research type

    Research Study

  • Full title

    Deriving and validating markers of cardiovascular disease from electrophysiological monitoring in pacemaker and defibrillators

  • IRAS ID

    359463

  • Contact name

    Anish Bhuva

  • Contact email

    a.bhuva@ucl.ac.uk

  • Sponsor organisation

    University College London

  • Clinicaltrials.gov Identifier

    Z6364106/2025/11/53, Data Protection Registration Number

  • Duration of Study in the UK

    7 years, 0 months, 1 days

  • Research summary

    Pacemakers and implantable cardioverter defibrillators (ICDs) are amongst the most advanced medical implants, improving outcomes and quality of life. However, every patient does not follow the same life-course. In some, the underlying heart condition can worsen, causing heart pump failure or uncomfortable ICD shocks, and there is high risk of other conditions, like stroke. We do not know why and when such events happen.

    Modern implants continuously monitor a range of health measurements, including detailed electrical signals recorded from wires in the heart. In this study, we will export data recorded by cardiac device sensors for detailed analysis. This will be used to identify mechanisms of disease and markers of device malfunction. Advanced pattern recognition techniques (‘artificial intelligence’) will be used to identify hidden patterns in the electrical activity of the heart.

    To test the potential for clinical use, two cohorts will be studied. A first group of patients will be followed up to look for changes in electrical signals over time. In a second group of patients, comparisons will be made against established markers of cardiac risk from routinely acquired non-invasive tests such as the electrocardiogram (ECG). Patients will be followed up for symptoms and any change in their health after one year.

  • REC name

    London - Hampstead Research Ethics Committee

  • REC reference

    26/LO/0065

  • Date of REC Opinion

    11 Feb 2026

  • REC opinion

    Further Information Favourable Opinion